Intellectual Property India Publishes Patent Application for 'A Process For Personalized Cancer Vaccine Development Using Neoantigens' Filed by Graphic Era

MUMBAI, India, Jan. 2 -- Intellectual Property India has published a patent application (202511102123 A) filed by Graphic Era, Dehradun, Uttarakhand, on Oct. 23, 2025, for 'a process for personalized cancer vaccine development using neoantigens.'

Inventor(s) include Deependra Pratap Singh.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a process for personalized cancer vaccine development using neoantigens (101-106) derived from tumor-specific mutations identified via next-generation sequencing. The process integrates bioinformatics analysis (102), neoantigen prediction (103), peptide synthesis (104), ...